Close
Back to LOGC Stock Lookup

LogicBio Therapeutics (LOGC) – Business Wire

Nov 16, 2022 08:23 AM Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics
Oct 3, 2022 07:15 AM Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine
Apr 27, 2021 08:00 AM CANbridge Pharmaceuticals Announces Strategic Collaboration with LogicBio Therapeutics and Licenses to Gene Delivery and Editing Platforms
Apr 13, 2021 07:00 AM AavantiBio Deepens AAV Manufacturing Capabilities with Key Hires to Support Strategic Growth

Back to LOGC Stock Lookup